A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2003
The purpose of this clinical research study is to learn if atazanavir is associated with serum LDL cholesterol in HIV-infected subjects following a substitution of atazanavir for their previously administered protease inhibitor.
Epistemonikos ID: 9d4257c53b587138b326c16a3a1eb83398a74625
First added on: Dec 01, 2021